518 related articles for article (PubMed ID: 10329563)
1. Role of hemagglutinin cleavage for the pathogenicity of influenza virus.
Steinhauer DA
Virology; 1999 May; 258(1):1-20. PubMed ID: 10329563
[TBL] [Abstract][Full Text] [Related]
2. [The role of cleavage activation of the hemagglutinin by host and bacterial proteases in the induction of the pathogenesis of influenza viruses].
Tashiro M
Nihon Rinsho; 1997 Oct; 55(10):2633-9. PubMed ID: 9360383
[TBL] [Abstract][Full Text] [Related]
3. [Potentiation of infectivity and pathogenesis of influenza virus by host and bacterial proteases].
Nagatake T
Nihon Rinsho; 2003 Nov; 61(11):1892-6. PubMed ID: 14619427
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the pathogenicity of members of the newly established H9N2 influenza virus lineages in Asia.
Guo YJ; Krauss S; Senne DA; Mo IP; Lo KS; Xiong XP; Norwood M; Shortridge KF; Webster RG; Guan Y
Virology; 2000 Feb; 267(2):279-88. PubMed ID: 10662623
[TBL] [Abstract][Full Text] [Related]
5. The hemagglutinin: a determinant of pathogenicity.
Böttcher-Friebertshäuser E; Garten W; Matrosovich M; Klenk HD
Curr Top Microbiol Immunol; 2014; 385():3-34. PubMed ID: 25031010
[TBL] [Abstract][Full Text] [Related]
6. Influenza viruses, cell enzymes, and pathogenicity.
Rott R; Klenk HD; Nagai Y; Tashiro M
Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 2):S16-9. PubMed ID: 7551406
[TBL] [Abstract][Full Text] [Related]
7. Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation.
Chen J; Lee KH; Steinhauer DA; Stevens DJ; Skehel JJ; Wiley DC
Cell; 1998 Oct; 95(3):409-17. PubMed ID: 9814710
[TBL] [Abstract][Full Text] [Related]
8. Expression of influenza B virus hemagglutinin containing multibasic residue cleavage sites.
Brassard DL; Lamb RA
Virology; 1997 Sep; 236(2):234-48. PubMed ID: 9325231
[TBL] [Abstract][Full Text] [Related]
9. MDCK cells that express proteases TMPRSS2 and HAT provide a cell system to propagate influenza viruses in the absence of trypsin and to study cleavage of HA and its inhibition.
Böttcher E; Freuer C; Steinmetzer T; Klenk HD; Garten W
Vaccine; 2009 Oct; 27(45):6324-9. PubMed ID: 19840668
[TBL] [Abstract][Full Text] [Related]
10. [Correlation between structure and pathogenicity of myxoviruses (author's transl)].
Rott R; Klenk HD; Scholtissek C
Arzneimittelforschung; 1977 Jan; 27(1B):208-12. PubMed ID: 576826
[TBL] [Abstract][Full Text] [Related]
11. Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus.
Stevens J; Corper AL; Basler CF; Taubenberger JK; Palese P; Wilson IA
Science; 2004 Mar; 303(5665):1866-70. PubMed ID: 14764887
[TBL] [Abstract][Full Text] [Related]
12. Influenza virus activating host proteases: Identification, localization and inhibitors as potential therapeutics.
Garten W; Braden C; Arendt A; Peitsch C; Baron J; Lu Y; Pawletko K; Hardes K; Steinmetzer T; Böttcher-Friebertshäuser E
Eur J Cell Biol; 2015; 94(7-9):375-83. PubMed ID: 26095298
[TBL] [Abstract][Full Text] [Related]
13. Use of animal models to understand the pandemic potential of highly pathogenic avian influenza viruses.
Belser JA; Szretter KJ; Katz JM; Tumpey TM
Adv Virus Res; 2009; 73():55-97. PubMed ID: 19695381
[TBL] [Abstract][Full Text] [Related]
14. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
[TBL] [Abstract][Full Text] [Related]
15. The structure and receptor binding properties of the 1918 influenza hemagglutinin.
Gamblin SJ; Haire LF; Russell RJ; Stevens DJ; Xiao B; Ha Y; Vasisht N; Steinhauer DA; Daniels RS; Elliot A; Wiley DC; Skehel JJ
Science; 2004 Mar; 303(5665):1838-42. PubMed ID: 14764886
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of and immunity to avian influenza A H5 viruses.
Katz JM; Lu X; Frace AM; Morken T; Zaki SR; Tumpey TM
Biomed Pharmacother; 2000 May; 54(4):178-87. PubMed ID: 10872716
[TBL] [Abstract][Full Text] [Related]
17. Pathogenic potential of North American H7N2 avian influenza virus: a mutagenesis study using reverse genetics.
Lee CW; Lee YJ; Senne DA; Suarez DL
Virology; 2006 Sep; 353(2):388-95. PubMed ID: 16828833
[TBL] [Abstract][Full Text] [Related]
18. Identification of trypsin I as a candidate for influenza A virus and Sendai virus envelope glycoprotein processing protease in rat brain.
Le TQ; Kawachi M; Yamada H; Shiota M; Okumura Y; Kido H
Biol Chem; 2006 Apr; 387(4):467-75. PubMed ID: 16606346
[TBL] [Abstract][Full Text] [Related]
19. The cleavage of the hemagglutinin protein of H5N2 avian influenza virus in yeast.
Wang CY; Luo YL; Chen YT; Li SK; Lin CH; Hsieh YC; Liu HJ
J Virol Methods; 2007 Dec; 146(1-2):293-7. PubMed ID: 17727967
[TBL] [Abstract][Full Text] [Related]
20. Alterations in caspase cleavage motifs of NP and M2 proteins attenuate virulence of a highly pathogenic avian influenza virus.
Zhirnov OP; Klenk HD
Virology; 2009 Nov; 394(1):57-63. PubMed ID: 19747708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
